All Posts

Summary: Reata Pharmaceuticals has a PDUFA data for Omaveloxolone for FA 2/28/23. The previous PDUFA date was extended 3 months after...

Summary: The upcoming readout from ETNB includes Phase 2b data from the pegozafermin trial in NASH. This is a Suspected Mover for Q1...

Last updated 4/11/23 Summary: Many exciting blood cancer & disease catalysts are coming throughout the year See the table below for some...

Summary: Many exciting blood cancer & disease catalysts are coming throughout the year See the table below for upcoming catalysts and become a Pro member for all catalyst events & dates Already a Pro member? Check out the full list of Big Movers !     Table 1 . Blood Cancer & Disease Catalysts & Assets Sign up for a Pro Membership to see all catalyst event dates! Learn more here Article history: Originally posted 2/21/23; last updated 4/11/23

Lot's of catalysts still coming Q1 2023, see more details and Catalyst Calendar below... 💬 Connect with us and fellow traders → in our...

Lot's of catalysts still coming in February, more details below... Last week hedge funds had to report their Q4 holdings, we analyzed 35+...

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Originally posted 2/16/23; last updated 4/28/23 Summary: Many exciting eye disease catalysts are coming throughout the year See the table...

Summary: Many exciting eye disease catalysts are coming throughout the year See the table below for upcoming catalysts and become a Pro member for all catalyst event dates Already a Pro member? Check out the full list of Big Movers ! Table 1 . Eye Disease Catalysts & Assets Sign up for a Pro Membership to see all catalyst event dates! Learn more here           Article history: Originally posted 2/15/23 Last updated 4/28/23

Last updated 4/26/23 Summary: Many exciting heart disease catalysts are coming throughout the year See the table below for some upcoming...